Racing medications and the future of the New York Racing Association were among the topics discussed Aug. 5 at the eighth Institute on Racing and Gaming Law in Saratoga Springs, N.Y.
During its meeting Nov. 2, in Louisville, Ky., the board of directors of the Racing Medication and Testing Consortium (RMTC) announced future plans regarding anabolic steroids and out-of-competition drug testing, and received an update on ongoing projects related to the development of withdrawal times for therapeutic medications.
In a meeting Oct. 9, the Kentucky Equine Drug Research Council committed $1.5 million to fund a three-year program with the Racing Medication and Testing Consortium that will research and determine appropriate withdrawal guidelines for therapeutic medications commonly administered to racehorses in training.
The Kentucky Equine Drug Research Council has allotted $1.5 million over three years to partner with the Racing Medication and Testing Consortium on a research project to determine withdrawal guidelines and threshold levels of therapeutic medications.
The Board of Directors of the Racing Medication and Testing Consortium approved a plan developed by Dr. Rick Sams of The Ohio State University to establish guidelines for withdrawal times for therapeutic medications utilized by racetrack veterinarians.
Dr. Scot Waterman,executive director of the Racing Medication Testing Consortium, was awarded the John K. Goodman Alumni Award from the University of Arizona Race Track Industry Program Thursday at The Symposium on Racing and Gaming being held this week near Tucson.
Scot Waterman, executive director of the national Racing Medication and Testing Consortium, said the group has made significant progress the last year in getting racing jurisdictions to adopt its chapter on medication and model rules, a uniform set of medication and drug-testing policies.
The Racing Medication and Drug Testing Consortium reached unanimous agreement Tuesday on several sections of a model drug-testing policy that will be brought to various state regulatory agencies for review later this year.
- By Ray Paulick
By Ray Paulick -- Progress continues in the areas of medication and drug-testing, and those involved in the process should not let a "lack of easy answers" stand in their way.
The National Thoroughbred Racing Association announced Wednesday that Dr. Scot Waterman will fill the new position of director of procedures and methods for the NTRA Racing Integrity and Drug Testing Task Force. Waterman will be based in Lexington.
Most Popular Stories
- Bayern Cruises to Pennsylvania Derby Win
- Untapable Unstoppable in Grade I Cotillion
- Miss Behaviour Romps in Charles Town Oaks
- Game On Dude, Won Three Big 'Caps, Retired
- California Chrome Draws Rail in PA Derby
- Suffolk Open to Any Viable Plans for Racing
- Featured Horse Profile: Artemis Agrotera
- Artemis Agrotera Gets Up to Win Gallant Bloom
- Thank You Marylou Coasts Clear in Dogwood
- Top Filly Princess of Sylmar Retired